← All trials
NCT01694849
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2012
- Primary completion
- Feb 1, 2015
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 270
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- GenfitLead sponsor
- University of SevilleOverall official - principal investigator
- Virginia Commonwealth UniversityOverall official - principal investigator
- University of TurinOverall official - principal investigator
- Radboud UniversityOverall official - principal investigator
- GenfitStudy director
- NaturalphaCollaborator
- Premier Research GroupCollaborator
- Newcastle UniversityOverall official - principal investigator
- University of AntwerpOverall official - principal investigator
- Gottfried Wilhelm Leibniz Universität HannoverOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.